<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Iranian Heart Association</PublisherName>
				<JournalTitle>Iranian Heart Journal</JournalTitle>
				<Issn></Issn>
				<Volume>16</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>09</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>mpact of Low-Dose Heparin on Accurate Anticoagulation during Cardiopulmonary Bypass and Postoperative Blood Loss in Cardiac Surgery</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>11</FirstPage>
			<LastPage>15</LastPage>
			<ELocationID EIdType="pii">83171</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mitra</FirstName>
					<LastName>Golmohammadi</LastName>
<Affiliation>Department of Cardiac Anesthesiology, Seyed Al-Shohada Hospital,Urmia University of Medical Sciences, Urmia,I.R.Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Saeidi</LastName>
<Affiliation>Department of Anesthesiology,Seyed Al-Shohada Hospital. Urmia University of Medical Sciences, Urmia, I.R.Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Hamid Reza</FirstName>
					<LastName>Khalkhali</LastName>
<Affiliation>Department of Biostatician Epidemiology and Biostatistics, Urmia University of Medical Sciences, Urmia, I.R.Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>02</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>Background:Activated clotting time (ACT) is most commonly measured for monitoring the anticoagulation effect of heparin during cardiopulmonary bypass (CPB).The aim of this study was to compare the standard heparin dose (300IU/kg) with lower doses to achieve ACTof 480 sec during CPB.Methods:In this prospective, randomized, double-blind clinical trial,120 patients (40/group) who underwent first-time elective coronary artery bypass grafting were randomized into 3groups A, B, and C receiving an initial heparin dose of 200, 250, and 300 IU/kg. Extra incremental heparin (50 IU/kg) was added if requiredto achieve a target ACT of 480 sec before initiating CPB. Postoperative blood loss was measured from the time of heparin reversal until the chest drains were removed 48h after operationin the intensive care unit. Results:The study groups were similar in demographic data. Target ACT was achieved in 32.5%, 50%, and 65% of the patients in groups A, B, and C—respectively—after the initial dose of heparin (P=0.051). The postoperative mean blood loss in the 2 groups of B and C (13.14±1.07 and 12.5±0.79mL/kg, respectively) was lower than that in group A (15.97±1.31mL/kg) (P=0.58). However, this difference between the 3 groups was not statically significant. The mean total dose of heparin in groups A and B was lower than that in group C (P=0.002).Conclusions:Thepatients receiving lower doses of heparin to achieve the target ACTdid not havelower postoperative blood loss. An initial heparin dose of 300 IU/kg was most often sufficientto reach the target ACT withthelowest incremental dose of heparin.(Iranian Heart Journal 2015; 16(3): 11-15)</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Heparin</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cardiopulmonary bypass</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Activated clotting time</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Blood loss</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.iha.org.ir/article_83171_9d9901965e1072a85529f00e0a5e5aa6.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Iranian Heart Association</PublisherName>
				<JournalTitle>Iranian Heart Journal</JournalTitle>
				<Issn></Issn>
				<Volume>16</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>09</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Adherence to Hemovigilance Protocols on Storage, Preparation, and Administration among Nurses in the Open-Heart Intensive Care Unit</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>16</FirstPage>
			<LastPage>21</LastPage>
			<ELocationID EIdType="pii">83170</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mohsen</FirstName>
					<LastName>Ziyaeifard</LastName>
<Affiliation>Department of Anesthesiology, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, I.R. Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Manizheh</FirstName>
					<LastName>Ahani</LastName>
<Affiliation>Department of Anesthesiology, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, I.R. Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Rasoul</FirstName>
					<LastName>Azarfarin</LastName>
<Affiliation>Department of Anesthesiology, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, I.R. Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Amad Eslam</FirstName>
					<LastName>JamalGolzari</LastName>
<Affiliation>Departmentof Anesthesiology and Intensive Care, Tabriz University of Medical Sciences, Tabriz, I.R. Iran</Affiliation>

</Author>
<Author>
					<FirstName>Masood</FirstName>
					<LastName>Mohseni</LastName>
<Affiliation>Department of Anesthesiology, School of Medicine, Rasoul-Akram Hospital, Iran University of Medical Sciences, Tehran, I.R. Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>02</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>Background:Adherence to blood storage, preparation, and administration standards has an important role in preventing blood-transfusion errors. In addition, the blood-transfusion rate following open-heart surgery is quite high. The aim of this study was to assess the adherence to hemovigilance standards on blood storage, preparation, and administration among nurses in the intensive care unit (ICU).Methods:One hundred nurses of the Open-Heart ICU of Rajaie Cardiovascular, Medical, and Research Center, Tehran, Iran, participated in this descriptive study. The nurses’ practice was supervised from the time of the entrance of the blood unit to the ICU until the end of the transfusion process. The ICU nurses’ hemovigilance practice was compared with the Iranian Ministry of Health and Medical Education’s standards. The nurses&#039; demographic and occupational characteristics were evaluated regarding the scores of the hemovigilance standards in their practice.Results:Concerning the standards of blood transfusion, 93% of the study nurses adhered to the protocols on blood-unit preservation, 84% on preparation, and 92% on transfusion. There were no statistically significant differences between the nurses’ age, sex, work experience, education, last transfusion workshop participation and practice assessment, number of blood-transfusion procedures performed per month, and achieved standard scores on blood storage, preparation, and administration (all P&gt;0.05). Conclusions:The study nurses achieved 85% of the standard scores on the preservation, preparation, and transfusion of blood units. The demographic and occupational characteristics of the ICU nurses had no effect on their hemovigilance practice. (Iranian Heart Journal 2015; 16(3): 16-21)</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Blood transfusion</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Nurses’ practice</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Standards</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Intensive Care Unit</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.iha.org.ir/article_83170_54504ac4de692e2ed530130e8da592ae.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Iranian Heart Association</PublisherName>
				<JournalTitle>Iranian Heart Journal</JournalTitle>
				<Issn></Issn>
				<Volume>16</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>09</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Association between Diastolic Function Parameters and MRI T2 Measurements in a Sample of Iranian Patients with Major Thalassemia</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>12</FirstPage>
			<LastPage>17</LastPage>
			<ELocationID EIdType="pii">83172</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Fatemeh</FirstName>
					<LastName>Rajabipour</LastName>
<Affiliation>Pediatric Department of Baharlou Hospital, Tehran University of Medical Sciences, Tehran, I.R.Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Seyed Abdolhossein</FirstName>
					<LastName>Tabatabaei</LastName>
<Affiliation>Department of Cardiology, Shariati Hospital,Tehran University of Medical Sciences, Tehran, I.R.Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Atoosa</FirstName>
					<LastName>Mostafavi</LastName>
<Affiliation>Department of Cardiology, Shariati Hospital,Tehran University of Medical Sciences, Tehran, I.R.Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Seyedeh Sahel</FirstName>
					<LastName>Rasoulighasemlouei</LastName>
<Affiliation>Department of Cardiology, Shariati Hospital,Tehran University of Medical Sciences, Tehran, I.R.Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Siamak</FirstName>
					<LastName>Khavandi</LastName>
<Affiliation>Department of Cardiology, Shariati Hospital,Tehran University of Medical Sciences, Tehran, I.R.Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>02</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>Background: The aim of the present study was to investigate the relationship between the echocardiographic indices of diastolic dysfunction and MRI T2 measurements, indicating myocardial iron loadings, in patients with thalassemia major and normal left ventricular ejection fractions. Methods: A series of consecutive patients with known thalassemia major under treatment with regular blood transfusions and iron chelation therapy were enrolled in the current study between July 2012 and June 2015 at Baharlou Hospital, Tehran, Iran. All the patients underwent cardiac MRI with the measurement of T2 for the liver and heart, echocardiographic examination with tissue Doppler assessment, and serum ferritin assay. The correlation between diastolic function parameters and T2 measurements was assessed using statistical software. Standard diastolic indices, comprising early (E) and late (A) transmitral peak flow velocities and early deceleration time (DT), were recorded. Results: The mean E/A, mean E/E′, and mean E′ were 2.09±0.54, 0.07±0.011, and 14±1.40 cm/s, respectively. The mean deceleration time (dt) was 190.97±35.89. The average serum ferritin level was 1498±783.08 ng/mL (range =212.7 to &gt;3000 ng/mL). The mean cardiac T2 derived MRI was 26.58±7.54 ms. The frequencies of the different severities of myocardial iron loading based on myocardial T2 were as follows: 44 (80%) normal, 4 (7.3%) mild, 2 (3.6%) moderate, and 5 (9.1%) severe. MRI T2 did not have a significant correlation with E/A (r=0.091; P=0.508), E′ (r=0.130; P=0.345), E/E′ (r=0.005; P=0.971), and dt (r=0.028; P=0.838). Hepatic iron loading based on the MRI T2 values also did not have any correlation with the echocardiographic indices of left ventricular diastolic dysfunction—namely E/A (r=0.151; P=0.270), E′ (r=0.034; P=0.804), E/E′ (r=0.083; P=0.547), and dt (r=0.128; P=0.351). Conclusions: None of the echocardiographic diastolic function parameters examined in this study were found to be suitable for cardiac surveillance in transfusion-dependent patients affected by thalassemia major. Longitudinal studies are needed to evaluate the utility of echocardiographic and MRI parameters to predict cardiac events. At the moment, we cannot recommend the replacement of cardiac MR and T2 measurements, indicating myocardial iron loading, by Doppler echocardiography in patients with a normal systolic function. (Iranian Heart Journal 2016; 17(3):12-17)</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">diastolic dysfunction</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Thalassemia Major</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hemoglobin disorders</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">iron overload</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.iha.org.ir/article_83172_450f8bff9e8ec3ad6a53125d226fe3d0.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Iranian Heart Association</PublisherName>
				<JournalTitle>Iranian Heart Journal</JournalTitle>
				<Issn></Issn>
				<Volume>16</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>09</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Depression Status and Related Factors in Patients with Heart Failure</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>22</FirstPage>
			<LastPage>27</LastPage>
			<ELocationID EIdType="pii">83169</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Atefeh</FirstName>
					<LastName>Ghanbari</LastName>
<Affiliation>Department of  Nursing, Social Determinant of Health Research Center, Guilan University of Medical Sciences, Rasht, I.R. Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Fatemeh</FirstName>
					<LastName>Moaddab</LastName>
<Affiliation>Department of  Nursing, Social Determinant of Health Research Center, Guilan University of Medical Sciences, Rasht, I.R. Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Arsalan</FirstName>
					<LastName>Salari</LastName>
<Affiliation>Department  of  Cardiology,  Guilan  Interventional  Cardiovascular  Research  Center,  Heshmat  Hospital,  Guilan  University  of  Medical Sciences, Rasht, I.R. Iran</Affiliation>

</Author>
<Author>
					<FirstName>Ehsan Kazem</FirstName>
					<LastName>Nezhad Leyli</LastName>
<Affiliation>Department of  Biostatistics, Social Determinant of Health Research Center, Guilan University ofMedical Sciences, Rasht, I.R. Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>02</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>Background:Among patientswith heart failure, patients withdepressive symptoms2-3times higher than inpatients withoutsymptoms of depressionareat increased riskof mortality.The aim ofthis studywas todetermine depression status and related factorsinpatientswith heart failure in 2012-13.Methods:In this descriptive cross-sectional study, 239 patients with heart failure who referred to Dr.Heshmat hospital in Rasht in 2012-13 were assessed. Data were collected using theCardiac Depression Scale, Charlson Comorbidity Index,and NYHA classification system. Data wereanalyzed with SPSSusingdescriptive statistics (frequency, percentage, mean,and standard deviation) and inferential statistics (Kolmogorov–Smirnov test for normal distribution of data,correlation chi-square, t-test,and logistic regression).Results:The results showed that 138 (57.7%) patients haddepressive symptoms.Inthelogistic regressionanalysis,only education and supplementary insurance as a significant predictor of cognitive status were identified,which indicated that thepatients with supplementary insurance and higher education levels were more likely to maintain an optimal cognitive function.Conclusions:Since more than half of the subjects had depressive symptoms, we recommend that depressive symptomsbe assessedand care plans be plannedbased on it.(Iranian Heart Journal 2015; 16(3): 22-27)</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">depression</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">patients</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Heartfailure</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.iha.org.ir/article_83169_0d36d554e131368685427acccc334be5.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Iranian Heart Association</PublisherName>
				<JournalTitle>Iranian Heart Journal</JournalTitle>
				<Issn></Issn>
				<Volume>16</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>09</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Sleep Quality in Patients with Heart Failure:Comparison Between Patients and Non-Patients in Yazd, Iran (2014)</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>28</FirstPage>
			<LastPage>37</LastPage>
			<ELocationID EIdType="pii">83167</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mahdieh</FirstName>
					<LastName>Momayyezi</LastName>
<Affiliation>Research Center for Prevention and Epidemiology of Non-Communicable Diseases, Shahid Sadoughi University of Medical Sciences, Yazd, I.R. Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Hossein</FirstName>
					<LastName>Fallahzadeh</LastName>
<Affiliation>Research Center for Prevention and Epidemiology of Non-Communicable Diseases, Shahid Sadoughi University of Medical Sciences, Yazd, I.R. Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Razie</FirstName>
					<LastName>Barzegar</LastName>
<Affiliation>Faculty of Health, Shahid Sadoughi University of Medical Sciences, Yazd, I.R. Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>02</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>Background:Heart failure is a common and dangerous life-threatening disease, with an impact on various aspects of life such as sleep quality. This study was conducted to determine sleep quality in patients with heart failure (HF) and its correlates.Methods:This case-control study was conducted on 160 individuals referring to Afshar Heart Hospital in Yazd through convenience sampling. After diagnostic tests (i.e.,angiography and echocardiography) and examinations by physicians, 80 patients with HF and 80 healthy individuals (control group) were selected. Data were collected using a questionnaire. The statistical analyses included descriptive statistics, the Mann–Whitney test,and the Kruskal–Wallis test using SPSS (version 16).Results:The patients had an average Pittsburgh Sleep Quality Index(PSQI) score of 5.5 (SD=0.3) with a median of 5. Around 43% of the patients compared with around 34% of the comparison group were identified as poor sleepers; these differences, however, were not statistically significant. The educational level (P=0.033), type of job (P=0.028), history of myocardial infarction (P=0.03), severity of pain (P=0.04), and fatigue (P=0.02) were related to sleep quality. The average daily sleep duration reported by the patients was nearly 6 hours. The mean sleep latency was 20 min amongthepatients. Getting up to urinate was the most common reason for waking up during the night.Conclusions:Increasing the awareness ofpatients withHF about improving sleep and encouraging them to participate in regular courses can improve the quality of their sleep and prevent sleepdisorders.(Iranian Heart Journal 2015; 16(3): 28-37)</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">PatientsHeart failureSleep qualityPittsburgh Sleep Quality IndexPSQI</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.iha.org.ir/article_83167_faff78ae9252e2aa0f2b9f721cb89398.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Iranian Heart Association</PublisherName>
				<JournalTitle>Iranian Heart Journal</JournalTitle>
				<Issn></Issn>
				<Volume>16</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>09</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Effect of Vitamin D Deficiency on Coronary Artery Stenosis</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>38</FirstPage>
			<LastPage>44</LastPage>
			<ELocationID EIdType="pii">83166</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Atoosa</FirstName>
					<LastName>Mostafavi</LastName>
<Affiliation>Department of Cardiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, I.R. Iran</Affiliation>

</Author>
<Author>
					<FirstName>Shabahang</FirstName>
					<LastName>Jafarnejad</LastName>
<Affiliation>Department of Cardiology, Shahid Rajaie Hospital, Mazandaran University of Medical Sciences, Tonkabon, I.R. Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Soheila</FirstName>
					<LastName>Khavandi</LastName>
<Affiliation>Department of Cardiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, I.R. Iran</Affiliation>

</Author>
<Author>
					<FirstName>Seyed Abdolhossein</FirstName>
					<LastName>Tabatabaee</LastName>
<Affiliation>Department of Cardiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, I.R. Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>02</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>ackground:Vitamin D is a prohormone that has recently been reported to modulate the inflammatory process and probably atherosclerosis.There isconflicting evidence infavor of the impact of hypovitaminosisof vitamin D on coronary artery stenosis. The aim of this study was to evaluatethe relationship between 25(OH) vitamin D and the extent and severity of coronary artery stenosis in sample of the Iranian population undergoing elective coronary artery angiography.Methods:Patients undergoing elective coronary artery angiography were included in this case-control study.Significant coronary artery stenosis was defined as stenosis&gt;60% of any major coronary arteryand &gt;50% fortheleft main artery as evaluated by quantitative coronary angiography.Results:Hypovitaminosis D was observed in 60.2% of 224 patients. The patientsweredivided according to their vitamin D level (i.e., &lt;10, 11–20,and 21–30) and also based on thepercentageof their coronary artery stenosis(i.e., normal coronary artery, insignificant stenosis,and significant stenosis).A higher vitamin Dlevel was associated with age. Hypovitaminosis D had no association with persistence,extent, and severity of coronary artery stenosis.Conclusions:Hypovitaminosis D was not significantly associated withtheincidence of diabetes mellitus, hypertension,and dyslipidemia.At present, the data regarding the causal link between vitamin D status and coronary artery stenosis are conflicting.These conflicting findingsmay be due tofactors relating to the studydesigns, ethnicity, confounding factors,and other coronaryartery diseaserisk factors. Further research isneeded to determine whether this association doesexist.(Iranian Heart Journal 2015; 16(3): 38-44</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Coronary artery stenosis Cardiovascular disease Vitamin D deficiency</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.iha.org.ir/article_83166_5f2938f1950b0a2fc4c97ed71df05f63.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Iranian Heart Association</PublisherName>
				<JournalTitle>Iranian Heart Journal</JournalTitle>
				<Issn></Issn>
				<Volume>16</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>09</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Application of Nanotechnology in Device Promotion in Cardiology: A Promising Horizon for Nanocardiology toward Personalized Medicine</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>45</FirstPage>
			<LastPage>53</LastPage>
			<ELocationID EIdType="pii">83165</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Peyman</FirstName>
					<LastName>Keyhanvar</LastName>
<Affiliation>Rajaie Cardiovascular,Medical and Research Center, Iran University of Medical Sciences, Tehran, I.R. Iran
Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, I.R. Iran</Affiliation>

</Author>
<Author>
					<FirstName>Neda</FirstName>
					<LastName>Bohlouli</LastName>
<Affiliation>Rajaie Cardiovascular,Medical and Research Center, Iran University of Medical Sciences, Tehran, I.R. Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Sajad</FirstName>
					<LastName>Bahrami</LastName>
<Affiliation>Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, I.R. Iran.
Student Research Committee, Iran University of Medical Sciences, Tehran,I.R. Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Ali</FirstName>
					<LastName>Yousefzadeh</LastName>
<Affiliation>Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research, Tehran, I.R. Iran</Affiliation>

</Author>
<Author>
					<FirstName>Shabnam</FirstName>
					<LastName>Madadi</LastName>
<Affiliation>Rajaie Cardiovascular,Medical and Research Center, Iran University of Medical Sciences, Tehran, I.R. Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>02</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>Cardiovascular diseasessuch as coronary artery disease, stroke,and atherosclerosis constitute some ofthe most challenging problems in the medical fieldbecause of their high mortality rates. Nanotechnology in medicine/nanomedicine has several applications indifferent medical fields,especially in cardiology. Recent advances in nanotechnology and nanomedicinehave created many opportunities for cardiovascular diseases, from diagnosis, treatment, and monitoring to drug delivery and nanoscale surgery. We reviewed recent applicationsof nano-enabled devicesin cardiology suchas targeted drug delivery, nanocoateddrug-eluting stents, injectable peptide nanofibers, anticoagulation applications,and post-surgical monitoring.(Iranian Heart Journal 2015; 16(3): 45-53)</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">NanotechnologyNanomedicineNanocardiologyPersonalized medicine</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.iha.org.ir/article_83165_04d524031f29c89d78cae864bd6f0de7.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Iranian Heart Association</PublisherName>
				<JournalTitle>Iranian Heart Journal</JournalTitle>
				<Issn></Issn>
				<Volume>16</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>09</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Large Left Atrial Myxoma Concomitant with Three-Vessel Coronary Artery Disease: A Rare Presentation of Heart Disease</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>54</FirstPage>
			<LastPage>56</LastPage>
			<ELocationID EIdType="pii">83163</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Hamid</FirstName>
					<LastName>Hoseinikhah</LastName>
<Affiliation>Department of Cardiac Surgery, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad,I.R.Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Mehdi</FirstName>
					<LastName>Fathi</LastName>
<Affiliation>Department of Cardiac Surgery, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad,I.R.Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Alireza</FirstName>
					<LastName>Sepehri Shamlo</LastName>
<Affiliation>Department of Cardiac Surgery, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad,I.R.Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Aliasghar</FirstName>
					<LastName>Moinipour</LastName>
<Affiliation>Department of Cardiac Surgery, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad,I.R.Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>02</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>We describe a 67-year-old man with a primary diagnosis of left atrial myxoma. Preoperative coronary angiography revealed a significant three-vessel disease. The patient underwent surgery, comprising the complete resection of the left atrial mass concomitant with coronary artery bypass grafting. He had good recovery without any complications in the early and late follow-up. There was no residual tumor or recurrence. The histopathological examination of the mass confirmed the diagnosis of the left atrial myxoma.(Iranian Heart Journal 2015;16(3):54-56)</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">MyxomaSurgical procedureCoronary artery bypass</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.iha.org.ir/article_83163_2f01222e0a208c0dd5818c558c5f88d4.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Iranian Heart Association</PublisherName>
				<JournalTitle>Iranian Heart Journal</JournalTitle>
				<Issn></Issn>
				<Volume>16</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>09</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Left Ventricular Clot due to Wild-Type Homozygous Factor V Leiden Mutation: A Case Report</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>57</FirstPage>
			<LastPage>59</LastPage>
			<ELocationID EIdType="pii">83164</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Farahnaz</FirstName>
					<LastName>Nikdoust</LastName>
<Affiliation>Department of Cardiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran,I.R.Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Mahdieh</FirstName>
					<LastName>Emami</LastName>
<Affiliation>Department of Cardiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran,I.R.Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Seyed Abdolhussein</FirstName>
					<LastName>Tabatabaei</LastName>
<Affiliation>Department of Cardiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran,I.R.Iran.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>02</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>Factor V Leiden (FVL) mutation has been identified as a frequent risk factor for life-threatening venous thromboembolic events. We describe a 39-year-old man admitted with sudden-onset blurred vision and mild lower-limb paresthesia with a positive activated protein C resistance test. The polymerase chain reaction confirmed wild-type homozygous FVL mutation. Transthoracic echocardiography revealed a highly elongated mobile mass attached to the akinetic cardiac apex, which extended to the left ventricular outflow tract. The thrombosis was removed by thrombectomy through aortotomy. The patient was in good clinical condition atthe last follow-up. (Iranian Heart Journal 2015;16(3):57-59)</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Factor V Leiden</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Mutation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Thrombosis</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.iha.org.ir/article_83164_a456e3aa3c4eabc5db513f2eba293f7c.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
